D
Vaxcyte, Inc. PCVX
$30.25 -$0.20-0.66% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -18.37% -2.65% -32.93% 19.87% -35.45%
Total Depreciation and Amortization 2.36% 1.86% 6.55% 29.13% 12.52%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -64.75% -18.37% 168.45% -25.08% 75.11%
Change in Net Operating Assets 168.04% -1,892.56% -108.51% 474.90% 89.45%
Cash from Operations 27.13% -49.26% -83.50% 49.99% 23.71%
Capital Expenditure 63.53% 10.91% 21.15% 2.31% -222.90%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -41.70% 128.47% 40.03% -2,021.71% 90.56%
Cash from Investing -36.96% 122.13% 39.24% -1,040.49% 82.17%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -46.52% 0.95% -99.61% 1,274.14% -86.50%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 86.45% -387.56% 88.38% -1,552.39% 82.91%
Cash from Financing 231.75% -84.53% -99.68% 1,272.71% -86.51%
Foreign Exchange rate Adjustments -31.74% -13.19% 124.21% -295.46% -123.26%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 2.24% 93.81% -224.56% 672.73% -143.37%